How should circular nucleotide sequences be represented in patent applications?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2412.05(b), circular nucleotide sequences in patent applications…

Read More

How are artificially introduced variations in nucleic acid sequences represented?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2412.05(c) provides guidance on representing artificially introduced variations…

Read More

What are the limitations on who can be named as a representative in a power of attorney for inter partes reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 6 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. There are specific limitations on who can be named as…

Read More

What is the ‘representative number of species’ concept in written description?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The ‘representative number of species’ concept is crucial in demonstrating…

Read More